| 000 | 00822 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516095220.0 | ||
| 264 | 0 | _c20120814 | |
| 008 | 201208s 0 0 fre d | ||
| 022 | _a0370-629X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCollignon, J | |
| 245 | 0 | 0 |
_a[Will targeted therapies replace chemotherapy?]. _h[electronic resource] |
| 260 |
_bRevue medicale de Liege _c2012 |
||
| 300 |
_a29-36 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 700 | 1 | _aJerusalem, G | |
| 773 | 0 |
_tRevue medicale de Liege _gvol. 67 Spec No _gp. 29-36 |
|
| 999 |
_c21857757 _d21857757 |
||